Integral Ad Science Holding Corp. (NASDAQ:IAS) Shares Purchased by Invenomic Capital Management LP

Invenomic Capital Management LP lifted its holdings in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 52.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 895,061 shares of the company's stock after buying an additional 309,752 shares during the period. Invenomic Capital Management LP owned about 0.55% of Integral Ad Science worth $9,344,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. Alta Fox Capital Management LLC acquired a new stake in Integral Ad Science during the 4th quarter valued at $61,000. BNP Paribas Financial Markets acquired a new stake in Integral Ad Science during the 4th quarter valued at $120,000. ClearAlpha Technologies LP acquired a new stake in Integral Ad Science during the 4th quarter valued at $143,000. PEAK6 LLC acquired a new stake in Integral Ad Science during the 4th quarter valued at $146,000. Finally, Handelsbanken Fonder AB purchased a new position in shares of Integral Ad Science during the 4th quarter worth $162,000. 95.78% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Lisa Utzschneider sold 8,367 shares of Integral Ad Science stock in a transaction that occurred on Wednesday, May 7th. The stock was sold at an average price of $7.37, for a total transaction of $61,664.79. Following the sale, the chief executive officer now owns 349,574 shares of the company's stock, valued at approximately $2,576,360.38. The trade was a 2.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Over the last three months, insiders sold 86,222 shares of company stock worth $636,252. Corporate insiders own 2.00% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have weighed in on IAS. Raymond James increased their price target on Integral Ad Science from $11.00 to $13.00 and gave the stock an "outperform" rating in a research note on Tuesday. Morgan Stanley reduced their price target on Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating on the stock in a research note on Thursday, April 17th. Oppenheimer reissued an "outperform" rating on shares of Integral Ad Science in a research note on Friday, February 28th. Scotiabank began coverage on Integral Ad Science in a research note on Friday, February 28th. They set a "sector perform" rating and a $12.00 price target on the stock. Finally, Baird R W lowered Integral Ad Science from a "strong-buy" rating to a "hold" rating in a research note on Friday, March 28th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, Integral Ad Science currently has a consensus rating of "Moderate Buy" and an average price target of $13.55.

Integral Ad Science Trading Down 0.9%

Shares of IAS traded down $0.08 during trading hours on Wednesday, hitting $8.08. The stock had a trading volume of 167,618 shares, compared to its average volume of 1,019,433. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.71 and a current ratio of 3.71. The firm has a market cap of $1.32 billion, a P/E ratio of 40.38, a P/E/G ratio of 1.06 and a beta of 1.55. The company's fifty day simple moving average is $7.78 and its 200 day simple moving average is $9.70. Integral Ad Science Holding Corp. has a 12-month low of $6.26 and a 12-month high of $13.62.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.02. The company had revenue of $134.07 million during the quarter, compared to the consensus estimate of $129.20 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. Equities research analysts forecast that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.